Streptococcus agalactiae Activities

Key points

  • ÐÇ¿ÕÓéÀÖ¹ÙÍø's Streptococcus Laboratory is a reference center for Streptococcus agalactiae and other streptococcal pathogens of public health importance.
  • Domestically, the laboratory supports national population-based surveillance for invasive disease.
  • The lab also supports training and development of improved strain surveillance methods.
A computer-generated image of Streptococcus agalactiae, which are also called group B strep bacteria.

Background

S. agalactiae are bacteria that are commonly called group B Streptococcus or group B strep bacteria. They cause infection in people of all ages that is collectively called group B strep disease.

These bacteria are a common cause of severe infections in newborns during the first weeks of life. More recently, experts recognized the increasing impact invasive group B strep disease has on adults.

Keep Reading: Group B Strep Disease

Surveillance activities

The laboratory supports ÐÇ¿ÕÓéÀÖ¹ÙÍø's Active Bacterial Core surveillance (ABCs) through the following activities:

  • Serotyping S. agalactiae isolates
  • Antimicrobial susceptibility testing
  • Strain characterization by whole genome sequencing
Keep Reading: ABCs

Typing and characterization

S. agalactiae are currently divided into 10 serotypes based on type-specific capsular antigens. The serotypes are designated as Ia, Ib, II, III, IV, V, VI, VII, VIII, and IX.

Methods

There are multiple methods to perform S. agalactiae serotyping:

  • Lancefield precipitation test
  • Latex agglutinationA
  • Real-time polymerase chain reaction (PCR)1
  • Conventional PCR2
  • Whole-genome sequencing3

Real-time PCR

Real-time PCR assays target the cfb gene (CAMP factor) in order to detect S. agalactiae. They are useful for detection directly from clinical specimens when culture is negative or unavailable. View a list of primer and probe sequences:

Get ÐÇ¿ÕÓéÀÖ¹ÙÍø support‎

Public health departments can request epidemiology and laboratory support via e-mail.
Request a consult
Print
Content Source:
National Center for Immunization and Respiratory Diseases; Division of Bacterial Diseases
  1. Several kits are commercially available.
  1. Breeding KM, Ragipani B, Lee KD, Malik M, Randis TM, Ratner AJ. Sci Rep. 2016;2(6):38523.
  2. Imperi M, Pataracchia M, Alfarone G, Baldassarri L, Orefici G, Creti R. J Microbiol Methods. 2010;80(2):212–4.
  3. Metcalf BJ, Chochua S, Gertz RE Jr, et al. Clin Microbiol Infect. 2017;pii: S1198-743X(17):30118–0.